Contents
Contents
Methadone bundle double billing happens when a provider bills again for a treatment bundle, or for counseling or lab work that the payer has already paid for inside it. The second bill can come from the clinic or an outside laboratory. In the Connecticut cases, the government alleged that Medicaid paid for testing inside a weekly bundle, then paid an outside lab for the same work. Taxpayers paid twice.
An opioid treatment program bundle pays for a defined period of care. Medicare’s weekly opioid treatment program payment covers seven consecutive days, with at least one covered drug or nondrug service required during that week. Medication, counseling, therapy and toxicology are part of the treatment covered by the payment framework. Eligible intake, reassessment, take-home medication and additional counseling have their own add-ons.
Medicare identifies the weekly methadone bundle as G2067. A weekly payment and a daily medication record describe different units. The dosing record shows medication supplied, while counseling and laboratory records show the other work behind a claim.
Medicaid programs set their own payment conditions. Washington’s July 2026 substance-use-disorder billing guide, for example, uses H0020 with its own bundle, treatment-planning and documentation requirements. The Connecticut cases below concern that state’s Medicaid treatment payments.
Office-based substance use disorder treatment has a separate Medicare monthly management bundle.
An inspector general review of Medicare opioid treatment program claims from January 2020 through September 2021 identified potentially improper payments for overlapping weekly bundles and take-home medication. The review flagged $10,418,939 for overlapping weekly bundles and $5,085,208 for take-home supplies overlapping bundles that already included medication. Both categories required contractor review.
The overlap can sit within the bundle claims or between a bundle and an extra medication claim. The covered period and the medication included in each payment show where the charges meet.
Outside-lab testing can generate a second charge for work already included in a methadone bundle. The Connecticut cases show how the treatment provider’s payment and the laboratory’s separate claim can reach the same payer through different businesses.
APT Foundation’s December 2017 settlement was $883,859. The Justice Department alleged that its weekly Medicaid methadone payment already included on-site drug testing, but APT referred testing to an outside laboratory that also billed Medicaid. The alleged conduct ran from January through November 2016. The lab’s separate claim put an additional charge against work the bundle had already covered.
The government also described what APT had been told. Its announcement traced notice through state regulations, a provider bulletin, an audit protocol and an audit of APT itself. For someone inside the business, those warnings connect the payment rule to the people who continued using the referral arrangement. The question reaches beyond who entered the laboratory charge to who knew the bundle already covered the testing.
Recovery Network of Programs settled for $354,367 in July 2020 over a similar allegation. From March through October 2017, according to the government, Medicaid paid a methadone bundle while an outside laboratory billed for the same included testing. A January 2016 audit had warned the provider about the issue. According to the government, the provider kept sending out included testing after the audit warning.
Connecticut Counseling Centers settled for $295,211 in May 2020. The government alleged duplicate Medicaid payment for urine testing from January 18 through December 31, 2016: testing already included in a weekly methadone bundle also appeared in an outside lab’s bill. Here too, a January 2016 audit had warned the provider.
The recurring connection is between the clinic’s bundle payment, its testing referral and the lab’s claim. A clinic employee may understand why the specimen went out. A laboratory employee may know how the resulting test was billed. The payer’s payment records connect those views.
Billing methadone-maintenance counseling again as separate psychotherapy is one example alleged in the Connecticut cases. New Era Rehabilitation Center’s April 2018 settlement was $1,378,533. The government alleged that the provider submitted separate psychotherapy claims while furnishing only methadone-maintenance counseling already included in its weekly Medicaid bundle.
The alleged billing ran from October 2009 through November 2013. The same counseling had a place inside the bundle and another identity on the separate claim. Calling it psychotherapy created the additional bill.
A counselor who delivered the session may recognize the work behind the psychotherapy claim. The clinical record shows what happened with the patient. In New Era, the government alleged that the separate claim gave included maintenance counseling a second price.
Evergreen Treatment Services allegedly rebilled weekly Medicare opioid-treatment services that Medicare had already paid for. Its June 2024 settlement was $1,453,982. The alleged duplication concerned the bundle payment itself.
The original services fell between January and July 2020. The Justice Department alleged that Evergreen knowingly billed those paid services again between January 8 and February 26, 2021. The bills arrived in different years, but charged for the earlier treatment.
The original payment is central to this pattern. The treatment record explains what care occurred, while the payment history shows that Medicare had already bought it.
A whistleblower’s complaint involving Acadia Healthcare’s Asheville facility alleged that staff copied group-therapy notes into records for patients who came for medication or assessments. At Journey to Hope Health and Healing, the government’s complaint alleged that staff backdated treatment plans, copying them between patients or creating years of plans without seeing the patient. Those allegations concern what care the records represented. Duplicate-payment evidence must also connect a second charge to care the payer already bought.
In a separate urine-testing case, the government alleged that Medicare paid different businesses for the same tests. The complaint alleged that Oaktree Medical Centre, Labsource and ProLab each billed Medicare for some of the same urine tests for one patient. Medicare denied Labsource’s claims and paid Oaktree and ProLab. The payment decisions identify where the alleged duplication became an expense to Medicare.
The evidence needs to connect the extra bill to care the payer already bought. We assess that connection with you, including how the provider’s payment rules fit the treatment and billing you know.
A counselor may recognize a session billed again as psychotherapy. A biller may recognize a paid episode that returned for another submission. Someone handling outside-lab referrals may know how included testing became a separate charge. Audit warnings and billing instructions can show what the provider knew when the charges continued.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. We assess how your knowledge connects the paid claims to the decisions inside the business, and which health care whistleblower lawyers have the experience your case needs.
If you recognize included testing or counseling coming back as another charge, speak with our Whistleblower Experts about how the bundle was billed twice. We build your strongest whistleblower case around the treatment and billing decisions you know, bring in healthcare whistleblower lawyers who know opioid treatment program payments, and stay beside you through the case.